Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Larry Allen

Concepts (576)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
235
2024
1952
28.810
Why?
Heart-Assist Devices
62
2023
485
13.380
Why?
Atrial Fibrillation
37
2022
324
5.160
Why?
Decision Making
25
2023
781
4.800
Why?
Patient Readmission
27
2023
608
4.500
Why?
Stroke Volume
43
2023
508
4.170
Why?
Decision Support Techniques
16
2022
351
3.880
Why?
Ventricular Dysfunction, Left
15
2023
359
3.350
Why?
Registries
47
2023
1759
3.150
Why?
Quality of Life
42
2023
2358
2.920
Why?
Heart Transplantation
16
2023
667
2.830
Why?
Cardiology
18
2022
259
2.660
Why?
Humans
322
2024
114757
2.650
Why?
Patient Participation
15
2023
360
2.620
Why?
Aged
135
2024
19094
2.340
Why?
Palliative Care
19
2023
641
2.280
Why?
Hospice Care
9
2021
185
2.250
Why?
Caregivers
16
2023
717
2.250
Why?
Guideline Adherence
11
2021
490
2.230
Why?
Defibrillators, Implantable
15
2022
286
2.200
Why?
Patient Discharge
27
2023
769
2.100
Why?
Ventricular Function, Left
17
2023
467
2.020
Why?
Hospitalization
41
2023
1752
2.010
Why?
United States
104
2024
12176
2.010
Why?
Practice Patterns, Physicians'
11
2020
1178
1.940
Why?
Medicare
31
2024
665
1.920
Why?
Terminal Care
9
2020
213
1.880
Why?
Male
155
2024
55579
1.760
Why?
Middle Aged
106
2023
26757
1.760
Why?
Female
160
2024
59507
1.720
Why?
Cardiotonic Agents
10
2021
119
1.700
Why?
Risk Assessment
32
2023
2973
1.680
Why?
Outpatients
10
2023
327
1.680
Why?
Aged, 80 and over
62
2023
6350
1.660
Why?
Patient Preference
6
2018
167
1.620
Why?
Ambulatory Care
7
2019
479
1.600
Why?
Myocardial Infarction
9
2023
927
1.490
Why?
Health Status
14
2023
723
1.490
Why?
American Heart Association
17
2023
264
1.420
Why?
Patient-Centered Care
12
2024
474
1.390
Why?
Anticoagulants
17
2022
547
1.390
Why?
Treatment Outcome
54
2023
9089
1.390
Why?
Withholding Treatment
5
2019
68
1.320
Why?
Delivery of Health Care
11
2023
833
1.310
Why?
Prognosis
29
2023
3334
1.310
Why?
Inpatients
5
2023
378
1.300
Why?
Heart Ventricles
6
2021
709
1.300
Why?
Aminobutyrates
7
2023
32
1.260
Why?
Family
4
2023
591
1.260
Why?
Aftercare
17
2023
186
1.240
Why?
Randomized Controlled Trials as Topic
10
2021
1214
1.230
Why?
Hospitals
10
2024
580
1.200
Why?
Practice Guidelines as Topic
12
2019
1393
1.190
Why?
Health Expenditures
5
2023
171
1.170
Why?
Angiotensin Receptor Antagonists
10
2023
76
1.170
Why?
Stroke
15
2022
1019
1.160
Why?
Cardiovascular Agents
3
2018
125
1.150
Why?
Risk Factors
46
2023
8627
1.110
Why?
Valsartan
6
2022
22
1.100
Why?
Biphenyl Compounds
7
2022
50
1.090
Why?
Angiotensin-Converting Enzyme Inhibitors
8
2023
179
1.090
Why?
Patient Care Management
3
2017
53
1.090
Why?
Cardiovascular Diseases
14
2022
1727
1.070
Why?
Surveys and Questionnaires
21
2023
4625
1.050
Why?
Health Knowledge, Attitudes, Practice
9
2021
1183
1.040
Why?
Consumer Health Information
3
2017
47
1.040
Why?
Drug Costs
4
2020
91
1.020
Why?
Adrenergic beta-Antagonists
7
2019
287
0.990
Why?
Heart Failure, Systolic
3
2018
20
0.980
Why?
Patient Selection
10
2019
641
0.970
Why?
Acute Coronary Syndrome
2
2023
254
0.960
Why?
Biomedical Research
3
2020
585
0.950
Why?
Death, Sudden, Cardiac
4
2021
160
0.950
Why?
Internet
4
2020
596
0.940
Why?
Anti-Arrhythmia Agents
4
2020
106
0.920
Why?
Quality Improvement
6
2021
951
0.920
Why?
Health Care Costs
7
2023
380
0.910
Why?
Angiotensin II Type 1 Receptor Blockers
2
2020
29
0.900
Why?
Patient Education as Topic
4
2018
679
0.900
Why?
Survival Analysis
14
2019
1218
0.890
Why?
Cardiovascular System
5
2022
125
0.880
Why?
Quality of Health Care
8
2024
573
0.880
Why?
Follow-Up Studies
25
2023
4420
0.870
Why?
Patient Reported Outcome Measures
10
2023
250
0.870
Why?
Cannabis
2
2022
384
0.870
Why?
Protease Inhibitors
2
2020
97
0.860
Why?
Physicians
7
2023
772
0.850
Why?
Heart Injuries
1
2023
36
0.830
Why?
Clinical Decision-Making
7
2023
268
0.820
Why?
Spirituality
1
2023
69
0.810
Why?
Diuretics
4
2023
66
0.780
Why?
Informed Consent
3
2023
161
0.770
Why?
Device Removal
2
2020
126
0.760
Why?
Catheter Ablation
4
2020
291
0.750
Why?
Insurance, Health
3
2017
244
0.740
Why?
Percutaneous Coronary Intervention
2
2023
444
0.740
Why?
Transitional Care
3
2021
34
0.720
Why?
Length of Stay
7
2018
949
0.720
Why?
Retrospective Studies
38
2023
12515
0.710
Why?
Health Policy
3
2021
334
0.700
Why?
Medication Adherence
6
2021
537
0.700
Why?
Adult
48
2023
30548
0.700
Why?
Population Health
1
2020
42
0.680
Why?
Attitude to Death
4
2023
62
0.670
Why?
Cardiomyopathies
3
2015
298
0.670
Why?
Biomarkers
7
2023
3416
0.670
Why?
Cause of Death
8
2020
362
0.660
Why?
Telemedicine
6
2024
663
0.660
Why?
Patient Rights
1
2019
10
0.660
Why?
Mineralocorticoid Receptor Antagonists
4
2018
38
0.650
Why?
Drug Substitution
2
2018
46
0.650
Why?
Propanolamines
1
2019
90
0.640
Why?
Medicaid
4
2021
407
0.640
Why?
Hemorrhage
10
2022
618
0.630
Why?
Time Factors
22
2023
6124
0.630
Why?
Interviews as Topic
9
2021
582
0.620
Why?
Pneumonia, Viral
2
2020
340
0.620
Why?
Quality Assurance, Health Care
3
2015
311
0.620
Why?
Coronavirus Infections
2
2020
332
0.620
Why?
Patient Care Team
4
2018
517
0.610
Why?
Hospices
5
2021
83
0.610
Why?
Health Status Indicators
3
2020
156
0.600
Why?
Manuscripts, Medical as Topic
1
2017
4
0.600
Why?
Warfarin
7
2022
135
0.590
Why?
Heart Diseases
2
2014
330
0.590
Why?
Attitude to Health
4
2019
406
0.580
Why?
Peer Review
1
2017
43
0.580
Why?
Peer Review, Research
1
2017
34
0.580
Why?
Physician-Patient Relations
3
2020
462
0.580
Why?
Cocaine
1
2019
153
0.580
Why?
Stress, Psychological
3
2021
944
0.570
Why?
Editorial Policies
1
2017
45
0.560
Why?
Disease Progression
14
2019
2387
0.560
Why?
Insurance Claim Review
2
2014
67
0.550
Why?
Advance Care Planning
2
2019
197
0.550
Why?
Heart Valve Prosthesis Implantation
2
2021
175
0.550
Why?
Prospective Studies
20
2022
6217
0.550
Why?
Angina, Unstable
3
2006
72
0.540
Why?
Health Plan Implementation
1
2017
132
0.540
Why?
Quality Indicators, Health Care
7
2021
287
0.530
Why?
Societies, Medical
5
2019
663
0.520
Why?
Comorbidity
13
2023
1449
0.520
Why?
Disease Management
6
2022
560
0.520
Why?
Clinical Trials as Topic
6
2019
935
0.520
Why?
Survival Rate
10
2020
1642
0.510
Why?
Aortic Valve Stenosis
2
2021
272
0.510
Why?
Digoxin
1
2015
26
0.500
Why?
Appointments and Schedules
1
2016
73
0.500
Why?
Healthcare Disparities
7
2023
479
0.500
Why?
Periodicals as Topic
1
2017
181
0.500
Why?
Heart Rate
4
2020
704
0.500
Why?
Natriuretic Peptide, Brain
5
2022
96
0.490
Why?
Cohort Studies
16
2023
4901
0.490
Why?
Activities of Daily Living
2
2016
350
0.480
Why?
Multimedia
1
2014
10
0.480
Why?
Frail Elderly
2
2013
105
0.480
Why?
Drug Prescriptions
2
2018
239
0.470
Why?
Health Personnel
2
2022
574
0.470
Why?
Proportional Hazards Models
13
2019
1080
0.470
Why?
Colorado
12
2021
4086
0.460
Why?
Severity of Illness Index
8
2018
2539
0.460
Why?
Population Surveillance
1
2017
392
0.460
Why?
Socioeconomic Factors
6
2022
1078
0.450
Why?
Skilled Nursing Facilities
2
2016
121
0.450
Why?
Fluid Therapy
1
2015
122
0.450
Why?
Acute Disease
7
2023
912
0.450
Why?
Marijuana Abuse
1
2016
212
0.450
Why?
Hip Prosthesis
1
2014
33
0.450
Why?
Hospital Mortality
8
2023
776
0.450
Why?
Shock, Cardiogenic
1
2014
53
0.440
Why?
Hyperkalemia
1
2013
26
0.440
Why?
Hand Strength
1
2014
95
0.440
Why?
Tetrazoles
6
2023
32
0.430
Why?
Preoperative Period
1
2013
103
0.430
Why?
Life Expectancy
2
2016
51
0.430
Why?
Electrocardiography
5
2023
562
0.430
Why?
Prosthesis Failure
1
2014
117
0.420
Why?
Algorithms
4
2022
1468
0.420
Why?
Drug Combinations
7
2022
286
0.420
Why?
Models, Statistical
2
2014
604
0.420
Why?
Patient Admission
3
2015
176
0.410
Why?
Arrhythmias, Cardiac
4
2022
278
0.410
Why?
Furosemide
2
2023
32
0.410
Why?
Coronary Artery Bypass
2
2011
198
0.410
Why?
Neprilysin
3
2023
47
0.400
Why?
Cardiac Catheterization
3
2020
534
0.400
Why?
Chronic Disease
10
2022
1590
0.400
Why?
Qualitative Research
8
2020
935
0.400
Why?
Comparative Effectiveness Research
1
2012
130
0.390
Why?
Aortic Valve
2
2021
400
0.390
Why?
Academic Medical Centers
3
2020
413
0.380
Why?
Emotions
7
2023
472
0.380
Why?
Social Environment
1
2013
283
0.380
Why?
Cross-Sectional Studies
9
2024
4409
0.380
Why?
Adaptation, Psychological
7
2023
547
0.370
Why?
Sleep Apnea, Obstructive
3
2020
200
0.370
Why?
Decision Support Systems, Clinical
2
2023
176
0.370
Why?
Age Factors
12
2020
2890
0.370
Why?
Myocarditis
2
2022
93
0.370
Why?
Health Literacy
4
2022
164
0.360
Why?
Income
3
2020
167
0.360
Why?
Research Report
5
2022
75
0.350
Why?
Patient Protection and Affordable Care Act
3
2017
99
0.350
Why?
Risk
4
2019
815
0.350
Why?
Communication
5
2023
747
0.350
Why?
Erythrocyte Indices
1
2009
28
0.350
Why?
Poverty
1
2013
442
0.330
Why?
Cardiologists
3
2018
40
0.330
Why?
Renal Insufficiency, Chronic
4
2021
486
0.330
Why?
Sex Factors
7
2021
1717
0.330
Why?
Consensus
6
2022
535
0.330
Why?
Hemodynamics
5
2023
1013
0.320
Why?
Delivery of Health Care, Integrated
3
2021
228
0.320
Why?
Weights and Measures
1
2008
7
0.320
Why?
Eligibility Determination
2
2021
60
0.310
Why?
Factor Xa Inhibitors
2
2020
138
0.310
Why?
Liver Function Tests
1
2009
103
0.310
Why?
Pain
2
2018
710
0.310
Why?
Surgical Wound Infection
1
2011
248
0.310
Why?
Anemia
1
2009
144
0.310
Why?
Administration, Oral
9
2021
731
0.310
Why?
Research Design
5
2023
931
0.310
Why?
Internationality
1
2008
144
0.290
Why?
Mitral Valve Insufficiency
1
2008
63
0.290
Why?
Multivariate Analysis
7
2013
1435
0.290
Why?
Erythrocytes
2
2009
591
0.290
Why?
Incidence
10
2018
2312
0.290
Why?
Mitral Valve
1
2008
87
0.290
Why?
Cardiac Resynchronization Therapy
2
2022
42
0.290
Why?
Betacoronavirus
2
2020
252
0.280
Why?
Acute Kidney Injury
1
2013
637
0.280
Why?
Referral and Consultation
5
2023
632
0.280
Why?
Models, Cardiovascular
1
2008
178
0.280
Why?
Breast Neoplasms
3
2023
1868
0.280
Why?
Hospitals, Community
2
2020
45
0.280
Why?
Prosthesis Design
4
2018
285
0.270
Why?
Patient Care
2
2023
103
0.270
Why?
Choice Behavior
2
2020
154
0.270
Why?
Pilot Projects
6
2022
1370
0.260
Why?
Patient Satisfaction
4
2020
583
0.260
Why?
Evidence-Based Medicine
4
2021
667
0.260
Why?
Cost-Benefit Analysis
4
2021
545
0.260
Why?
Frailty
2
2019
114
0.260
Why?
Cost of Illness
5
2020
254
0.260
Why?
Mass Screening
2
2010
1003
0.260
Why?
Prosthesis Implantation
2
2019
139
0.250
Why?
Prevalence
9
2020
2249
0.250
Why?
Patient Compliance
4
2019
525
0.250
Why?
Patient Acceptance of Health Care
4
2020
680
0.250
Why?
Marijuana Smoking
2
2020
224
0.240
Why?
Mortality
4
2020
288
0.240
Why?
Electric Countershock
3
2020
104
0.240
Why?
Kaplan-Meier Estimate
5
2018
815
0.240
Why?
Neoplasms
3
2023
2105
0.240
Why?
Digital Divide
1
2024
3
0.230
Why?
Depression
4
2020
1133
0.230
Why?
Mobile Applications
2
2024
140
0.230
Why?
Creatinine
3
2023
424
0.230
Why?
Infusions, Intravenous
3
2018
372
0.220
Why?
Reproducibility of Results
5
2023
2763
0.220
Why?
Congresses as Topic
3
2021
196
0.220
Why?
Clinical Coding
2
2014
19
0.220
Why?
Chest Pain
1
2023
80
0.220
Why?
Probability
3
2016
291
0.220
Why?
Urea
1
2023
68
0.220
Why?
Perinatal Care
1
2023
36
0.220
Why?
Isosorbide Dinitrate
1
2023
3
0.210
Why?
Hydralazine
1
2023
5
0.210
Why?
Troponin
1
2023
44
0.210
Why?
Denmark
1
2023
39
0.210
Why?
Drug Utilization
2
2015
167
0.210
Why?
Cardiac Rehabilitation
1
2023
33
0.210
Why?
Diabetes Mellitus, Type 2
3
2022
2097
0.210
Why?
Recovery of Function
4
2020
572
0.210
Why?
Death
1
2023
107
0.210
Why?
Pulmonary Artery
1
2008
1012
0.210
Why?
Atrial Appendage
1
2022
10
0.200
Why?
Pandemics
2
2020
1319
0.200
Why?
Patient Care Bundles
1
2021
17
0.200
Why?
Cognition
4
2021
989
0.190
Why?
Anxiety
3
2018
842
0.190
Why?
Advisory Committees
2
2021
208
0.190
Why?
Electrophysiologic Techniques, Cardiac
1
2021
70
0.190
Why?
Hypertension
3
2021
1059
0.190
Why?
Universities
1
2023
339
0.190
Why?
Trust
1
2022
105
0.190
Why?
Insurance, Health, Reimbursement
1
2021
88
0.190
Why?
Age Distribution
3
2012
339
0.180
Why?
Myocardial Contraction
2
2019
312
0.180
Why?
Relaxin
1
2020
15
0.180
Why?
Georgia
1
2020
62
0.180
Why?
Norway
1
2020
36
0.180
Why?
Health Systems Plans
1
2020
3
0.180
Why?
Platelet Aggregation Inhibitors
4
2020
400
0.180
Why?
Psychology
1
2021
81
0.180
Why?
Financing, Government
1
2020
40
0.180
Why?
Home Care Services
2
2020
222
0.180
Why?
Palliative Medicine
2
2018
14
0.180
Why?
Pyridones
1
2021
123
0.180
Why?
Health Services Misuse
1
2020
36
0.180
Why?
National Institutes of Health (U.S.)
1
2020
106
0.170
Why?
Diagnosis-Related Groups
2
2021
27
0.170
Why?
Health Resources
2
2012
122
0.170
Why?
Odds Ratio
5
2014
954
0.170
Why?
Thoracentesis
1
2019
8
0.170
Why?
Nurses
3
2018
145
0.170
Why?
Tertiary Care Centers
1
2020
126
0.170
Why?
Mandatory Programs
1
2019
15
0.170
Why?
Pharmaceutical Preparations
1
2021
168
0.170
Why?
Minimal Clinically Important Difference
1
2019
10
0.170
Why?
Dyspnea
3
2018
213
0.160
Why?
Extracorporeal Membrane Oxygenation
1
2022
240
0.160
Why?
Multicenter Studies as Topic
1
2020
249
0.160
Why?
Fatigue
3
2018
295
0.160
Why?
Mental Competency
1
2019
26
0.160
Why?
Atherosclerosis
1
2022
342
0.160
Why?
Coronary Artery Disease
3
2019
607
0.160
Why?
Text Messaging
1
2021
154
0.160
Why?
Home Infusion Therapy
1
2018
4
0.160
Why?
Guidelines as Topic
2
2017
244
0.160
Why?
Social Determinants of Health
1
2020
135
0.160
Why?
Fee-for-Service Plans
2
2018
83
0.160
Why?
Medical Marijuana
1
2020
97
0.160
Why?
Contraindications
2
2015
85
0.150
Why?
Thromboembolism
2
2021
93
0.150
Why?
Patient Safety
3
2021
278
0.150
Why?
Ventricular Function
1
2018
56
0.150
Why?
Attitude of Health Personnel
3
2020
977
0.150
Why?
Heart Failure, Diastolic
1
2018
20
0.150
Why?
Reimbursement Mechanisms
1
2018
77
0.150
Why?
Drug Administration Schedule
3
2020
718
0.150
Why?
Cost Savings
2
2021
74
0.150
Why?
Dose-Response Relationship, Drug
2
2014
1846
0.150
Why?
Heart Conduction System
1
2018
82
0.150
Why?
Spouses
1
2018
85
0.150
Why?
Mental Health
1
2023
560
0.150
Why?
Thrombosis
1
2021
297
0.150
Why?
Medical Records
1
2018
153
0.140
Why?
Quality Control
1
2017
144
0.140
Why?
Spiritual Therapies
1
2017
9
0.140
Why?
Vaccines
1
2022
375
0.140
Why?
Nervous System Diseases
1
2020
252
0.140
Why?
Blood Coagulation
1
2018
217
0.140
Why?
Caliciviridae Infections
1
2016
17
0.140
Why?
Drug Therapy, Combination
2
2019
954
0.140
Why?
Pain Management
2
2016
289
0.140
Why?
Databases, Factual
2
2012
1128
0.130
Why?
Mexiletine
1
2016
7
0.130
Why?
Amphetamine
1
2016
22
0.130
Why?
Predictive Value of Tests
4
2021
1796
0.130
Why?
Defibrillators
1
2016
16
0.130
Why?
Thrombolytic Therapy
1
2017
117
0.130
Why?
Truth Disclosure
1
2016
39
0.130
Why?
Public Health
1
2020
434
0.130
Why?
Emergency Service, Hospital
2
2023
1812
0.130
Why?
Bereavement
1
2016
49
0.130
Why?
Substance Abuse Detection
1
2016
62
0.130
Why?
Antihypertensive Agents
2
2023
429
0.130
Why?
Uncertainty
1
2016
96
0.130
Why?
Psychotherapy
1
2017
149
0.130
Why?
Social Security
1
2015
4
0.130
Why?
Medical Indigency
1
2015
11
0.130
Why?
Kidney
2
2020
1184
0.120
Why?
Waiting Lists
1
2017
211
0.120
Why?
Transplant Recipients
1
2016
140
0.120
Why?
Young Adult
7
2019
10463
0.120
Why?
Self Care
2
2019
350
0.120
Why?
Drug Monitoring
1
2016
184
0.120
Why?
Information Seeking Behavior
1
2015
35
0.120
Why?
Polypharmacy
1
2015
74
0.120
Why?
Glycogen Storage Disease Type IIb
1
2014
22
0.120
Why?
Cognitive Dysfunction
1
2019
284
0.120
Why?
Assisted Circulation
1
2014
25
0.120
Why?
Continuous Positive Airway Pressure
1
2015
51
0.120
Why?
Health Surveys
3
2023
443
0.120
Why?
Drug Hypersensitivity
1
2015
85
0.120
Why?
Patient Outcome Assessment
1
2015
121
0.110
Why?
Critical Care
1
2018
473
0.110
Why?
Cobalt
1
2014
46
0.110
Why?
Cooperative Behavior
1
2016
381
0.110
Why?
Calcium
1
2019
1103
0.110
Why?
Potassium
1
2013
128
0.110
Why?
Peripheral Arterial Disease
1
2019
380
0.110
Why?
Women's Health
1
2015
271
0.110
Why?
Data Collection
1
2016
622
0.110
Why?
Infant, Newborn
1
2023
5035
0.100
Why?
Antineoplastic Agents
2
2014
1895
0.100
Why?
Anthracyclines
1
2012
41
0.100
Why?
Geriatric Assessment
1
2013
176
0.100
Why?
Health Maintenance Organizations
1
2012
93
0.100
Why?
Drug Utilization Review
1
2012
57
0.100
Why?
Body Mass Index
2
2019
1958
0.100
Why?
Patients
2
2024
162
0.100
Why?
Sickness Impact Profile
1
2011
50
0.100
Why?
Monitoring, Physiologic
1
2013
248
0.100
Why?
Pregnancy
1
2023
5525
0.100
Why?
Diabetes Mellitus
1
2019
904
0.100
Why?
Echocardiography, Three-Dimensional
1
2012
48
0.100
Why?
Acculturation
1
2012
50
0.100
Why?
Tachycardia
1
2011
50
0.090
Why?
Echocardiography
1
2014
554
0.090
Why?
Myocardial Ischemia
1
2012
234
0.090
Why?
Hyponatremia
1
2011
37
0.090
Why?
Culture
1
2012
124
0.090
Why?
Lung Diseases
1
2017
696
0.090
Why?
Motivation
1
2015
494
0.090
Why?
Cognition Disorders
1
2015
477
0.090
Why?
Glomerular Filtration Rate
2
2013
604
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
916
0.090
Why?
Logistic Models
2
2013
1843
0.090
Why?
Antidiuretic Hormone Receptor Antagonists
1
2010
8
0.090
Why?
Health Services Research
1
2013
371
0.090
Why?
Minority Groups
1
2012
227
0.090
Why?
Erythropoiesis
1
2009
34
0.090
Why?
Confidence Intervals
3
2020
309
0.090
Why?
Benzazepines
1
2010
37
0.090
Why?
Injections, Intravenous
1
2010
201
0.090
Why?
Focus Groups
2
2023
385
0.080
Why?
Diagnosis, Differential
1
2014
1340
0.080
Why?
Electric Stimulation Therapy
1
2010
56
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2013
373
0.080
Why?
Endpoint Determination
1
2009
69
0.080
Why?
Residence Characteristics
1
2011
275
0.080
Why?
ROC Curve
1
2010
445
0.080
Why?
Bilirubin
1
2009
88
0.080
Why?
Aspartate Aminotransferases
1
2009
86
0.080
Why?
Alberta
1
2008
10
0.080
Why?
Actuarial Analysis
1
2008
21
0.080
Why?
Data Interpretation, Statistical
1
2010
322
0.080
Why?
United States Food and Drug Administration
1
2009
172
0.080
Why?
Syndrome
1
2009
334
0.080
Why?
Lung Neoplasms
2
2023
2199
0.080
Why?
Alanine Transaminase
1
2009
141
0.080
Why?
Alkaline Phosphatase
1
2009
143
0.080
Why?
Serum Albumin
1
2009
134
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2012
664
0.080
Why?
Substance-Related Disorders
1
2016
947
0.070
Why?
Social Support
3
2019
528
0.070
Why?
DNA
1
2014
1351
0.070
Why?
Insurance Coverage
2
2021
201
0.070
Why?
Child
2
2023
18352
0.070
Why?
Social Workers
2
2018
32
0.070
Why?
Ultrafiltration
1
2007
27
0.070
Why?
Heart Function Tests
1
2007
58
0.070
Why?
Benzimidazoles
1
2007
138
0.070
Why?
Liver Diseases
1
2009
254
0.070
Why?
Lung
1
2018
3546
0.060
Why?
Genomics
1
2010
639
0.060
Why?
Feasibility Studies
2
2020
737
0.060
Why?
Health Services Accessibility
1
2011
763
0.060
Why?
Vasodilator Agents
1
2007
303
0.060
Why?
Proteomics
1
2010
843
0.060
Why?
Diabetes Complications
1
2006
211
0.060
Why?
Natriuretic Peptides
1
2023
8
0.060
Why?
Combined Modality Therapy
1
2007
1122
0.060
Why?
Cardiac Surgical Procedures
1
2008
413
0.060
Why?
Critical Illness
1
2008
643
0.060
Why?
Prescriptions
1
2023
60
0.050
Why?
Cardiac Output
1
2023
142
0.050
Why?
Renin-Angiotensin System
1
2023
71
0.050
Why?
Magnetic Resonance Imaging
1
2014
3039
0.050
Why?
Heuristics
1
2022
8
0.050
Why?
Information Systems
1
2023
61
0.050
Why?
Sexism
1
2023
44
0.050
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2022
12
0.050
Why?
Multimorbidity
1
2022
34
0.050
Why?
Massachusetts
1
2022
134
0.050
Why?
Phenotype
2
2021
2812
0.050
Why?
Artificial Intelligence
1
2023
145
0.050
Why?
Sodium
1
2022
182
0.050
Why?
Program Development
1
2023
342
0.050
Why?
Return to Sport
1
2022
80
0.050
Why?
Critical Pathways
1
2022
74
0.050
Why?
Policy
1
2022
137
0.050
Why?
Exercise Test
1
2023
544
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2023
299
0.040
Why?
Attitude
1
2022
229
0.040
Why?
Urban Health Services
1
2020
60
0.040
Why?
International Classification of Diseases
1
2021
117
0.040
Why?
Organizations, Nonprofit
1
2020
17
0.040
Why?
Private Sector
1
2020
51
0.040
Why?
Rural Health Services
1
2020
93
0.040
Why?
Intracranial Embolism
1
2019
29
0.040
Why?
Stakeholder Participation
1
2020
73
0.040
Why?
Public Opinion
1
2020
59
0.040
Why?
Embolism
1
2019
43
0.040
Why?
Contraindications, Procedure
1
2019
11
0.040
Why?
Canada
1
2020
322
0.040
Why?
Visual Analog Scale
1
2019
31
0.040
Why?
Disease Susceptibility
1
2021
316
0.040
Why?
Myocardial Revascularization
1
2019
67
0.040
Why?
Hyperlipidemias
1
2019
122
0.040
Why?
Peripheral Vascular Diseases
1
2019
97
0.040
Why?
Sex Characteristics
1
2023
640
0.040
Why?
Observational Studies as Topic
1
2019
90
0.040
Why?
Peripheral Nervous System Diseases
1
2019
121
0.040
Why?
Quality-Adjusted Life Years
1
2019
101
0.040
Why?
Government Regulation
1
2018
46
0.040
Why?
Survival
1
2018
37
0.040
Why?
Sensitivity and Specificity
2
2017
1691
0.040
Why?
Treatment Failure
1
2019
332
0.040
Why?
Walk Test
1
2018
52
0.040
Why?
Hospitals, Rural
1
2018
31
0.040
Why?
Patient Health Questionnaire
1
2018
20
0.040
Why?
Policy Making
1
2018
81
0.040
Why?
Drug Dosage Calculations
1
2018
21
0.040
Why?
Peptide Fragments
1
2022
668
0.040
Why?
Exercise Tolerance
1
2019
213
0.040
Why?
Medicare Part D
1
2018
26
0.040
Why?
Hospitals, Urban
1
2018
127
0.040
Why?
Longitudinal Studies
2
2016
2386
0.040
Why?
Random Allocation
1
2018
335
0.040
Why?
Risk Reduction Behavior
1
2019
201
0.040
Why?
Recombinant Proteins
1
2020
1233
0.040
Why?
Single-Blind Method
1
2018
258
0.040
Why?
Glucose
1
2022
897
0.040
Why?
Risk Management
1
2018
89
0.040
Why?
Diphenoxylate
1
2016
5
0.040
Why?
Colorectal Neoplasms
1
2023
621
0.030
Why?
Atropine
1
2016
25
0.030
Why?
Loperamide
1
2016
10
0.030
Why?
Antidiarrheals
1
2016
15
0.030
Why?
Propensity Score
1
2018
224
0.030
Why?
Emotional Adjustment
1
2016
17
0.030
Why?
Karnofsky Performance Status
1
2016
36
0.030
Why?
Prostatic Neoplasms
1
2023
925
0.030
Why?
Voltage-Gated Sodium Channel Blockers
1
2016
5
0.030
Why?
Chromatography, Gas
1
2016
27
0.030
Why?
Cluster Analysis
1
2018
460
0.030
Why?
Gastrointestinal Agents
1
2016
60
0.030
Why?
Postoperative Period
1
2017
289
0.030
Why?
Medically Uninsured
1
2017
122
0.030
Why?
Data Accuracy
1
2016
48
0.030
Why?
Symptom Assessment
1
2016
119
0.030
Why?
Video Recording
1
2016
142
0.030
Why?
Life Change Events
1
2016
135
0.030
Why?
Physicians, Primary Care
1
2018
222
0.030
Why?
Lysosomal-Associated Membrane Protein 2
1
2014
26
0.030
Why?
Central Nervous System Stimulants
1
2016
139
0.030
Why?
Reference Values
1
2016
742
0.030
Why?
Linear Models
1
2017
770
0.030
Why?
Family Relations
1
2015
85
0.030
Why?
Treatment Refusal
1
2015
85
0.030
Why?
Intensive Care Units
1
2018
618
0.030
Why?
Polymerase Chain Reaction
1
2016
994
0.030
Why?
Morbidity
1
2014
277
0.030
Why?
DNA Mutational Analysis
1
2014
372
0.030
Why?
Proteinuria
1
2013
77
0.030
Why?
Hospitals, Veterans
1
2014
244
0.030
Why?
Imaging, Three-Dimensional
1
2016
513
0.030
Why?
Immunosuppressive Agents
1
2016
647
0.030
Why?
Systole
1
2013
171
0.030
Why?
Trastuzumab
1
2012
89
0.030
Why?
Global Health
1
2014
288
0.030
Why?
Chi-Square Distribution
1
2013
494
0.020
Why?
Antibiotics, Antineoplastic
1
2012
109
0.020
Why?
Hypoglycemic Agents
1
2019
1009
0.020
Why?
Precision Medicine
1
2015
338
0.020
Why?
Evidence-Based Practice
1
2013
185
0.020
Why?
Forecasting
1
2013
331
0.020
Why?
History, 21st Century
1
2012
160
0.020
Why?
Chemotherapy, Adjuvant
1
2012
333
0.020
Why?
History, 20th Century
1
2012
265
0.020
Why?
Medical Audit
1
2011
75
0.020
Why?
Managed Care Programs
1
2011
133
0.020
Why?
Needs Assessment
1
2011
313
0.020
Why?
Social Class
1
2011
204
0.020
Why?
Hypertension, Pulmonary
1
2019
1728
0.020
Why?
Health Care Rationing
1
2008
45
0.020
Why?
Databases as Topic
1
2007
63
0.020
Why?
Tomography, X-Ray Computed
1
2016
2269
0.020
Why?
Genetic Predisposition to Disease
1
2014
2099
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1361
0.010
Why?
Mutation
1
2014
3350
0.010
Why?
Adolescent
1
2017
17808
0.010
Why?
Animals
1
2012
31762
0.010
Why?
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)